Clínica Baviera, S.A. (BME: CBAV)

Market Cap	567.32M
Revenue (ttm)	243.31M
Net Income (ttm)	38.41M
Shares Out	16.30M
EPS (ttm)	2.36
PE Ratio	14.77
Forward PE	n/a
Dividend	1.57 (4.49%)
Ex-Dividend Date	Jul 16, 2024

Volume	903
Open	34.50
Previous Close	35.00
Day's Range	34.40 - 35.50
52-Week Range	20.50 - 39.50
Beta	0.67
Analysts	n/a
Price Target	n/a
Earnings Date	Nov 22, 2024

About Clínica Baviera

Clínica Baviera, S.A., a medical company, operates a network of ophthalmology clinics. The company is involved in the diagnosis, treatment, and monitoring of various types of visual disorders. Its clinics offers myopia, hyperopia, astigmatism, presbyopia, cataract, retina, pediatric ophthalmology, glaucoma, squint, cornea, neuroftalmología, and vías lagrimales treatments. The company is based in Madrid, Spain.

• Industry: Diagnostics & Research
• Sector: Healthcare
• CEO: Eduardo Baviera Sabater
• Employees: 1,254
• Stock Exchange: Madrid Stock Exchange
• Ticker Symbol: CBAV

Financial Performance

In 2023, Clínica Baviera's revenue was 227.07 million, an increase of 14.42% compared to the previous year's 198.45 million. Earnings were 35.97 million, an increase of 21.86%.